Profile data is unavailable for this security.
About the company
STENOCARE A/S is a Denmark-based company, which is engaged in the production of medical cannabis products to patients. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The Company distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.
- Revenue in DKK (TTM)5.67m
- Net income in DKK-24.58m
- Incorporated2017
- Employees8.00
- LocationStenocare A/SNyholmsvej 4, Randers NOeRANDERS 8930DenmarkDNK
- Websitehttps://stenocare.dk/
More ▼
Mergers & acquisitions
| Acquired company | STENO:CPH since announced | Transaction value |
|---|---|---|
| Canngros ApS | -36.12% | 1.77m |
Data delayed at least 15 minutes, as of Feb 16 2026 16:10 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Double Bond Phrmcutcl Intrntnl AB (publ) | 196.56k | -593.70k | 17.45m | 9.00 | -- | 2.07 | -- | 88.80 | -0.02 | -0.02 | 0.0035 | 0.056 | 0.027 | -- | 2.99 | 30,961.11 | -8.16 | -75.46 | -11.26 | -104.36 | 2,263.63 | -717.21 | -302.04 | -1,144.39 | -- | 0.78 | 0.00 | -- | -20.52 | 35.18 | 58.98 | -- | 114.06 | -- |
| Pila Pharma AB | 675.71k | -7.94m | 36.57m | 0.00 | -- | 32.33 | -- | 54.13 | -0.3702 | -0.3702 | 0.0315 | 0.0381 | 0.2406 | -- | 7.20 | -- | -282.78 | -113.42 | -602.96 | -128.21 | -679.51 | -118.10 | -1,175.22 | -1,491.09 | -- | -136.10 | 0.00 | -- | -47.03 | 17.47 | -13.21 | -- | -- | -- |
| ExpreS2ion Biotech Holding AB | 7.66m | -31.86m | 39.00m | 20.00 | -- | 1.25 | -- | 5.09 | -44.22 | -44.22 | 5.14 | 12.52 | 0.1305 | -- | 5.67 | 571,157.90 | -54.33 | -58.63 | -85.25 | -70.70 | 55.64 | -18.17 | -416.26 | -621.40 | -- | -- | 0.0433 | -- | -11.07 | -10.76 | 60.57 | -- | 5.08 | -- |
| XP Chemistries AB | 219.71k | -5.41m | 39.87m | 2.00 | -- | 1.43 | -- | 181.45 | -0.042 | -0.042 | 0.0017 | 0.126 | 0.0095 | 3.58 | 9.76 | 155,735.00 | -23.42 | -- | -25.03 | -- | -1,850.65 | -- | -2,461.64 | -- | 17.17 | -- | 0.00 | -- | -57.22 | -- | 11.26 | -- | -- | -- |
| Odi Pharma AB (publ) | 6.33m | -3.33m | 45.52m | 1.00 | -- | 220.56 | -- | 7.19 | -0.2851 | -0.2851 | 0.5266 | 0.016 | 1.33 | -- | 5.29 | 8,971,460.00 | -70.09 | -40.68 | -1,151.76 | -60.97 | -29.08 | -- | -52.61 | -95.17 | -- | -8.51 | 0.00 | -- | -85.94 | -- | -944.49 | -- | -- | -- |
| Oncozenge AB | 1.91m | -6.03m | 51.83m | 1.00 | -- | 7.90 | -- | 27.08 | -0.7136 | -0.7136 | 0.2282 | 0.7357 | 0.162 | -- | 3.75 | 2,713,000.00 | -51.09 | -- | -58.48 | -- | -- | -- | -315.33 | -- | -- | -610.07 | 0.4463 | -- | -- | -- | 45.37 | -- | -- | -- |
| Enorama Pharma AB | 2.70m | -54.01m | 55.25m | 5.00 | -- | -- | -- | 20.49 | -1.23 | -1.23 | 0.0595 | -0.0623 | 0.1413 | 2.71 | 2.45 | 764,600.00 | -283.01 | -88.96 | -526.84 | -127.92 | -302.88 | 15.72 | -2,002.90 | -488.89 | 0.5223 | -12.77 | -- | -- | 1,061.12 | 15.68 | 1.81 | -- | -- | -- |
| Arctic Bioscience AS | 29.13m | -28.73m | 60.37m | 22.00 | -- | 0.4649 | -- | 2.07 | -1.67 | -1.67 | 1.69 | 7.27 | 0.156 | 0.9957 | 4.02 | 1,998,510.00 | -15.39 | -15.49 | -18.84 | -17.83 | 28.45 | 28.52 | -98.62 | -125.49 | 0.3389 | -9.68 | 0.2202 | -- | 28.84 | 7.68 | -5.31 | -- | -- | -- |
| StenoCare A/S | 5.67m | -24.58m | 62.94m | 8.00 | -- | 25.37 | -- | 11.09 | -0.8176 | -0.8176 | 0.1569 | 0.0572 | 0.324 | -- | 3.80 | 709,217.50 | -140.37 | -45.69 | -201.07 | -59.64 | -- | -- | -433.19 | -739.04 | 1.32 | -6.51 | 0.526 | -- | -40.60 | -14.70 | -96.30 | -- | -64.95 | -- |
| Vivesto AB | 0.00 | -25.19m | 71.51m | 4.00 | -- | 0.3795 | -- | -- | -0.0664 | -0.0664 | 0.00 | 0.2483 | 0.00 | -- | -- | 0.00 | -21.35 | -- | -23.62 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 69.12 | -- | -- | -- |
| IRLAB Therapeutics AB | 60.35m | -64.84m | 109.90m | 31.00 | -- | 2.88 | -- | 1.82 | -1.56 | -1.56 | 1.40 | 0.6382 | 0.5172 | -- | 8.93 | 3,168,815.00 | -55.56 | -27.34 | -149.51 | -32.01 | -35.80 | -45.70 | -107.43 | -112.19 | -- | -4.29 | 0.3548 | -- | 1,566.57 | 415.48 | 53.26 | -- | 7.75 | -- |
| Isofol Medical AB (publ) | 0.00 | -38.44m | 119.57m | 6.00 | -- | 1.41 | -- | -- | -0.2698 | -0.2698 | 0.00 | 0.4291 | 0.00 | -- | -- | 0.00 | -43.21 | -61.58 | -51.19 | -82.71 | -- | -740.36 | -- | -861.94 | -- | -- | 0.00 | -- | -100.00 | -- | -17.31 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to Stenocare A/S's reporting currency: Danish Krone DKK
